Q&A – Patient testing
2cureX is happy to receive a number of questions and comments from our present and from potential future shareholders.
With the present Questions & Answers (Q&A) section, we would like to make these questions and their answers publicly available. Additional questions/comments should be mailed to info@2cureX.com.
Posted on 2020-06-02
If a patient contacts 2cureX, our medical staff evaluates the contact and refers the patient to one of our partnering hospitals. The hospital will then decide whether the patient could be enrolled in an ongoing clinical trial or is to be tested outside the trials.
Please contact 2cureX for more information
September 15, 2021 at 15:00 (CET)
Interview with CEO Fernando Andreu (organized by Mangold) Open participation. Details provided later.
September 23, 2021
CSO Ole Thastrup will speak at the conference “Week of Health and Innovation 2021” in Odense, Denmark
September 28, 2021
Redeye Medtech & Diagnostics Investor meeting
September 29, 2021
Mangold Investor Lunch